Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-19-060273

Director sold 6,000 shares at $47.50 ($285,000)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kurkijarvi Kalevi · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-09 Exercise or conversion : show line 1 in the form +6,000 $18.00 $108,000 34,400 D
2019-12-09 Sale : show line 2 in the form −6,000 $47.50 $285,000 28,400 D
Open-market sales · 6,000 sh · avg $47.50 · $285,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-12-09 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −6,000 $18.00 2024-11-13 6,000 6,000 D
Loading xslF345X03/doc4.xml…